Supha Pharmachem Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	5,269	4,053	40,417	5,098	5,048	900.34
Other Revenue	-	-	-	-	-	0.02
Revenue	5,269	4,053	40,417	5,098	5,048	900.36
Revenue Growth (YoY)	-84.25%	-89.97%	692.75%	1.00%	460.66%	3015.21%
Cost of Revenue	5,114	3,981	40,014	4,939	4,985	877.51
Gross Profit	154.88	71.12	403.24	159.69	63.09	22.85
Selling, General & Admin	17.35	18.09	21.46	16.24	11.14	6.07
Other Operating Expenses	81.26	40.73	47.24	76.29	34.19	9.57
Operating Expenses	98.81	59.21	69.27	94.04	46.07	16.24
Operating Income	56.07	11.91	333.97	65.65	17.02	6.62
Interest Expense	-	-26	-40.24	-0.72	-0.7	-0.11
Interest & Investment Income	3.4	1.29	0.94	-	-	-
Currency Exchange Gain (Loss)	106.82	106.82	209.87	8.27	-	0.03
Other Non Operating Income (Expenses)	-8.21	-50.18	0	0.76	-1.07	-
EBT Excluding Unusual Items	158.08	43.84	504.54	73.96	15.25	6.53
Pretax Income	158.08	43.84	504.54	73.96	15.25	6.53
Income Tax Expense	35.54	22.55	177.24	19.7	4.47	1.72
Net Income	122.54	21.29	327.3	54.26	10.78	4.81
Net Income to Common	122.54	21.29	327.3	54.26	10.78	4.81
Net Income Growth	-49.17%	-93.49%	503.20%	403.44%	124.31%	73.47%
Shares Outstanding (Basic)	649	403	403	403	403	403
Shares Outstanding (Diluted)	649	403	403	403	404	404
Shares Change (YoY)	9.07%	-	-	-0.12%	-0.03%	0.14%
EPS (Basic)	0.19	0.05	0.81	0.13	0.03	0.01
EPS (Diluted)	0.19	0.05	0.81	0.13	0.03	0.01
EPS Growth	-53.82%	-93.84%	503.20%	404.03%	124.37%	73.22%
Free Cash Flow	-10,042	-11,348	-741.61	204.57	112.33	-102.51
Free Cash Flow Per Share	-15.48	-28.14	-1.84	0.51	0.28	-0.25
Gross Margin	2.94%	1.75%	1.00%	3.13%	1.25%	2.54%
Operating Margin	1.06%	0.29%	0.83%	1.29%	0.34%	0.73%
Profit Margin	2.33%	0.53%	0.81%	1.06%	0.21%	0.53%
Free Cash Flow Margin	-190.59%	-280.03%	-1.84%	4.01%	2.23%	-11.39%
EBITDA	56.27	12.3	334.54	67.16	17.76	7.22
EBITDA Margin	1.07%	0.30%	0.83%	1.32%	0.35%	0.80%
D&A For EBITDA	0.2	0.39	0.57	1.51	0.74	0.6
EBIT	56.07	11.91	333.97	65.65	17.02	6.62
EBIT Margin	1.06%	0.29%	0.83%	1.29%	0.34%	0.73%
Effective Tax Rate	22.48%	51.43%	35.13%	26.63%	29.33%	26.39%
Revenue as Reported	5,417	4,161	40,628	5,098	5,048	900.36
Advertising Expenses	-	0.09	3.03	0.31	2.36	0.43

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.